| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia 30322
Received 27 March 2007/ Accepted 24 August 2007
When thymidylate production is diminished by a mutation affecting dCTP deaminase, Escherichia coli is known to use an alternate pathway involving deoxycytidine as an intermediate. The pathway requires the gene for any of three nucleoside diphosphate kinases (ndk, pykA, or pykF) and the gene for a 5'-nucleotidase (yfbR).
Published ahead of print on 7 September 2007.
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |